Discover 1,567 paid clinical trials in Paterson, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,567
Active & ResponsiveNew
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: Hackensack NJ, Paramus NJ, Pompton NJ, New York NY,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase3, Recruiting
Active & Responsive
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Hackensack NJ, New York NY, Morristown NJ, Queens NY,
Sponsor: PedAL BCU, LLC
Sex: All
Age: 0 - 21
Code: NCT05183035
Phase3, Recruiting
Active & Responsive
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes
for
Embryonal Tumor With Multilayered Rosettes
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 0+
Code: NCT04794686
Recruiting
Active & Responsive
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Location: Hackensack NJ, New York NY, Doylestown PA, Marlton NJ,
Sponsor: Orchestra BioMed, Inc
Sex: All
Age: 18+
Code: NCT06059638
Recruiting
Active & Responsive
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: Hackensack NJ, New York NY, Fairfax VA, Buffalo NY,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT07094204
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
for
Systemic Lupus Erythematosus
Location: Hackensack NJ, New York NY, Hershey PA, Atlanta GA,
Sponsor: NYU Langone Health
Sex: All
Age: 55+
Code: NCT05799378
Phase3, Recruiting
Active & Responsive
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
for
Osteogenic Sarcoma Recurrent
Location: Hackensack NJ, Houston TX
Sponsor: Hackensack Meridian Health
Sex: All
Age: 8 - 30
Code: NCT05726383
Phase2, Recruiting
Active & Responsive
GnRH for Luteal Support in IVF/ICSI/FET Cycles
for
Infertility
Location: Hasbrouck Heights NJ
Sponsor: University Reproductive Associates
Sex: Female
Age: 18 - 40
Code: NCT02357654
Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Hackensack NJ, New York NY, Richmond VA, Cleveland OH,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase1, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
Location: Hackensack NJ, New York NY, Mineola NY, Baltimore MD,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Active & Responsive
Pembrolizumab and Lenvatinib in Advanced Cervical Cancer
for
Cervical Cancer, Metastatic Cervical Cancer
Location: Hackensack NJ, Washington D.C. DC, Augusta GA
Sponsor: Georgetown University
Sex: Female
Age: 18+
Code: NCT04865887
Phase2, Recruiting
Active & Responsive
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
for
Multiple Myeloma in Relapse, Myeloma Multiple,
Location: Hackensack NJ, Boston MA, Atlanta GA, Tampa FL,
Sponsor: Kelonia Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07075185
Phase1, Recruiting
Active & Responsive
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
for
Endometrial Cancer, Ovarian Cancer, Ovarian Cancer Metastatic,
Location: Hackensack NJ, Fairfax VA, Buffalo NY, Cleveland OH,
Sponsor: Whitehawk Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07444814
Phase1, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Location: Hackensack NJ, New York NY, The Bronx NY, Summit NJ,
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07326566
Phase2, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Hackensack NJ, New York NY, New Brunswick NJ,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase3, Recruiting
Active & Responsive
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
for
Advanced Solid Tumors
Location: Hackensack NJ, Fairfax VA, Kingston, Toronto, Hamilton,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT05067283
Phase1, Recruiting
Active & Responsive
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Hackensack NJ, New York NY, Boston MA,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 12+
Code: NCT05533697
Phase1, Phase2, Recruiting
Active & Responsive
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer
for
Cancer Related Cognitive Decline, Non-metastatic Breast Cancer
Location: Hackensack NJ, Washington D.C. DC
Sponsor: Georgetown University
Sex: Female
Age: 18+
Code: NCT05256745
Phase1, Phase2, Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Hackensack NJ, New York NY, Mineola NY,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase1, Phase2, Recruiting
Active & Responsive
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
for
Prostate Cancer, Prostatic Neoplasms
Location: Hackensack NJ, New York NY, West Haven CT, New Haven CT,